Adalja, Amesh
Dr. Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health, and an Affiliate of the Johns Hopkins Center for Global Health. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. He actively practices infectious disease, critical care, and emergency medicine in the Pittsburgh metropolitan area.
Airo, Adriana
Adriana Airo is a Clinical Microbiologist and Program Head for the High Volume Serology Laboratory at the BC Centre for Disease Control. She is a Fellow of the Canadian College of Microbiologists who recently completed her Clinical Microbiology training at the University of Toronto in 2023. Prior to that, she completed her Bachelor of Science in Microbiology and Immunology from the University of British Columbia and her doctoral studies in Virology in the Department of Medical Microbiology & Immunology at the University of Alberta. In her PhD, she focused on elucidating the molecular mechanisms by which arboviruses such as Dengue and Zika viruses hijack cellular pathways and cause disease. Her areas of interest include viral hepatitis, emerging viral pathogens and zoonotic diseases.
Alexander, David
Dr. David Alexander is a PhD-trained microbiologist with a long-standing interest in the application of genomic technologies to infectious diseases. For the past 17 years, he has worked in the provincial public health laboratory system, first at the Public Health Ontario Laboratories in Toronto, then at the Saskatchewan Disease Control Laboratory in Regina. Since 2016, David has been a Scientist at the Cadham Provincial Laboratory. He provides support for assay validation and research activities and is actively involved with genomic surveillance of bacterial pathogens that cause foodborne illness and sexually transmitted infections.
Banerji, Versha
Dr. Versha Banerji, MD FRCPC obtained her MD and residency training in Internal Medicine and Hematology at the University of Manitoba. She then completed a post-doctoral fellowship in translational research at the Harvard Cancer Centre/ Dana-Farber Cancer Institute and Broad Institute of MIT. She is a Senior Scientist at the Paul Albrechtsen CancerCare Manitoba Research Institute, Associate Professor at the University of Manitoba, and a Clinician-Scientist at CancerCare Manitoba. She is the inaugural Director of the Chronic Lymphocytic Leukemia, Clinical Care, Education and Translational Research Unit at the University of Manitoba and CCMB and leads clinical trials and population-based treatment studies locally. She manages a multi-disciplinary research team in clinical, fundamental and translational research and is the principle investigator for local, national and international clinical trials at CancerCare Manitoba. Her own laboratory is evaluating novel therapeutics and the impact on mitochondrial function and metabolism.
Bogoch, Isaac
Dr. Isaac Bogoch is an Associate Professor at the University of Toronto in the Department of Medicine, and an Infectious Diseases specialist at the Toronto General Hospital with a focus on tropical diseases, HIV, and general infectious diseases. Dr. Bogoch works at the intersection of clinical medicine, epidemiology, public health, and policy. He divides his clinical and research time between Toronto and several countries in Africa and Asia. He collaborates with a team that models the spread of emerging tropical infectious diseases, and studies innovative and simple diagnostic solutions to improve the quality of medical care in low-resource settings.
Chagla, Zain
Dr. Chagla is an Associate Professor at McMaster University, and an Infectious Diseases Consultant. He is Medical Director of Infection Control, Head of Infectious Diseases Service, and Interim Senior Medical Director of Clinical Operations at St Joseph’s Healthcare Hamilton. He is a member of the Institute for Infectious Diseases Research (IIDR) at McMaster University, and a board director of AMMI-Canada (Association of Medical Microbiology and Infectious Diseases). Dr. Chagla holds a BSc and MD from Queen’s University, an Internal Medicine Residency from Western University, an Infectious Diseases Fellowship at McMaster University, and a Masters of Science (Infectious Diseases), and Diploma in Tropical Medicine from the London School of Hygiene and Tropical medicine.
Charles, Marthe
Dr. Charles has a MD MSc degree from Université de Montreal since 2010. She has completed her residency in Medical Microbiology and Infectious Diseases at University of Alberta in 2016. Now Division Head of the Medical Microbiology and Infection Prevention and Control at Vancouver Coastal Health for the last 7 years, her interest lays in more integrated diagnostics, increasing access and quality improvement. She currently oversees urogenital infections and molecular diagnostic at VCH. From an IPAC perspective, she is involved in laboratory assessment of self-disinfecting surfaces.
Chorlton, Sam
Sam Chorlton is a board-certified medical microbiologist and CEO of BugSeq Bioinformatics. After medical school at McMaster, Sam completed microbiology residency at the University of British Columbia. Sam then founded BugSeq Bioinformatics, a sequencing analysis company for clinical and public health labs. In this capacity, he oversees analysis for over 700 laboratories, including hospital, state and national labs. He has served as PI or investigator on projects for the US CDC and BARDA, including the development of rapid metagenomic and biothreat sequencing assays.
Chu, Angel
Angel Chu is an Infectious Diseases Physician, Clinical Assistant Professor, Cumming School of Medicine, and Medical Director, Calgary STI Clinic. She is also the former Vice-Chair of Immunize Canada.
Comeau, Jeannette
Dr. Jeannette Comeau is an Assistant Professor of Pediatrics at Dalhousie University and Pediatric Infectious Diseases Physician at IWK Health Centre in Halifax, NS. After completing her Doctor of Medicine at Dalhousie University, she went on to complete residency in Pediatrics and Paediatric Infectious Diseases both at McGill University. Prior returning home to Halifax, she completed a fellowship in Vaccinology at the National Centre for Immunisation Research & Surveillance, Sydney, Australia. In addition to her clinical responsibilities, Dr. Comeau is the Medical Director, Infection Prevention and Control, and the Medical Lead, Antimicrobial Stewardship at the IWK Health Centre. She is also an investigator at the Canadian Centre for Vaccinology focusing on vaccine policy, safety and hesitancy.
Constantinescu, Cora
Cora Constantinescu is a pediatrician, infectious disease physician and clinical associate professor in Calgary, AB. From seeing vaccine hesitant patients in clinic, to her academic pursuits in vaccine acceptance and surveillance, she has a strong passion for vaccine research and promotion. She holds a Masters in Medical Education and specializes in development and study of education interventions rooted in behavioral change theory. She has applied these skills to vaccine education for healthcare workers and the public and continues to be a vaccine advocate at the local and national levels.
Descamps, Philippe
Philippe Descamps is a Professor of Obstetrics and Gynaecology and has been Head of the Department in Obstetrics and Gynecology at the Angers University Hospital in Angers, France since 1999. In addition, he is the Director of the regional reference center for endometriosis, Endo Ref-Pays de Loire. Professor Descamps has been the FIGO Vice-President from 2021 until 2023 and a member of the FIGO Strategic Planning Committee since 2021 after having been elected as the French representative to the FIGO Council from 2015 to 2021. At a national level, he is President of the International Relations Committee and a member of both the Board and the Bureau of the French National College of Gynecologists and Obstetricians. He previously served as Vice-President of the French Society of Gynecological and Pelvic Surgery from 2011 to 2021. Professor Descamps’ clinical and surgical expertise in Obstetrics and Gynecology include endometriosis, and pelvic cancers.
Dionne, Kim
Kim Dionne is the Manager of Laboratory Services at Qikiqtani General Hospital in Iqaluit, NU. She received her educated at Algonquin College in Ottawa and worked as a generalist lab tech for 13 years before spending 5 years working in various locations in the Middle East. She worked for 17 years in the AFB lab at Johns Hopkins in Baltimore, MD before finally returning to Canada in 2019 to take the position at QGH.
Feld, Jordan
Dr. Feld is a Professor of Medicine at the University of Toronto, Ontario, Canada. He trained in GI and Hepatology at the University of Toronto and did post-doctoral training in the Liver Diseases Branch at the National Institutes of Health in laboratory and clinical research in viral hepatitis. After completing a Masters in Public Health at the Johns Hopkins Bloomberg School of Public Health, he returned to Toronto. He is a Professor of Medicine at the University of Toronto and holds the R. Phelan Chair in Translational Liver Research as a clinician-scientist at the Toronto Centre for Liver Disease in the Toronto General Hospital where he leads a large clinical and translational research program focused primarily on viral hepatitis and its complications.
Gin, Alfred
Alfred Gin obtained his BScPharm undergraduate degree from the University of Manitoba and his PharmD at University of Buffalo. He is an Infectious Diseases Clinical Pharmacist at the Health Sciences Centre Winnipeg with over 30 years of I.D. experience working closely with the Section of Infectious Diseases. Alfred has a cross-appointment as an Assistant Professor with the Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba. Alfred has a keen interest in optimizing antimicrobial use and approaching questions from a broader clinical perspective. He is active on many professional committees, working groups and organizations. He enjoys problem solving challenges and technology.
Glassman, Heather
Heather Glassman is a Medical Microbiologist and Infection Prevention and Control physician at Vancouver General Hospital. She is a Clinical Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia. She completed her medical degree and Medical Microbiology residency training at the University of Alberta.
Goldfarb, David
David Goldfarb is a Medical Microbiologist and Pediatric Infectious Disease specialist based at BC Children’s Hospital and BC Women’s Hospital + Health Centre where he also serves as the Associate Head of the Department of Pathology and Laboratory Medicine. Dr. Goldfarb had completed his training and certification in Pediatrics, Infectious Diseases and Medical Microbiology at the University of Ottawa. Prior to coming to UBC, he had academic appoints at McMaster University and the University of Botswana. Dr. Goldfarb’s research focuses primarily on novel diagnostic, management and prevention strategies for pediatric infectious diseases, particularly in resource limited settings.
Grant, Jennifer
Dr. Jennifer Grant trained in Medicine, Infectious Diseases and Medical Microbiology at McGill and has practiced Microbiology and Infectious Diseases in Vancouver since 2007. She has represented both CHICA (now IPAC) and AMMI Canada as a board member, and is now the program head for bacteriology and mycology at BCCDC with an interest in health systems, antimicrobial stewardship and quality of patient care. Away from medicine, Jennifer is mother to Sierra, Alexis and Océanne, and avid skier and mountain biker, making use of the coastal mountains whenever possible.
Hanomansing, Ian
Ian Hanomansing was born in Port-of-Spain, Trinidad, and grew up in Sackville, New Brunswick. He graduated with an honours B.A. in political science and sociology from Mount Allison University in Sackville and has a law degree from Dalhousie University in Halifax. He began his broadcasting career at CKDH Radio in Amherst, Nova Scotia, working at radio stations in Moncton and Halifax before joining CBC in Halifax in 1986. His assignments took him to Toronto the following year and eventually to Vancouver, where he was a national reporter for fourteen years. He hosts the CBC News' flagship program THE NATIONAL from Vancouver on Fridays and Sundays, and is also the host of CROSS COUNTRY CHECKUP on CBC Radio and CBC News Network
Hatchette, Todd
Dr. Hatchette is a Medical Microbiologist and Infectious disease physician who is the Chief of Service for the Division of Microbiology, QEII Health Science Center and the Co-Director of the Virology and Immunology. He is a Professor in the Department of Pathology with a cross-appointments in the Departments of Immunology and Microbiology and Medicine where he is a consultant Infectious Diseases. In addition, Dr. Hatchette is the past President of the Association of Medical Microbiology and infectious Diseases (AMMI) Canada.
Isabel, Sandra
At Université Laval, Dr Sandra Isabel's research focuses on improving the prevention and diagnostics of pediatric infections through innovative technologies such as multi-omics and artificial intelligence.
Johnstone, Jennie
Dr. Johnstone obtained her medical degree from Dalhousie University. She then moved to Edmonton, Alberta where she completed her Internal Medicine and Infectious Disease training at the University of Alberta. Following her residency, she completed a clinical research fellowship in Edmonton and subsequently, completed her PhD in Health Research Methodology (Epidemiology) at McMaster University. Dr. Johnstone is currently the Division Head of Infectious Diseases at the University of Toronto, is an Associate Professor in the Departments of Medicine and Laboratory Medicine and Pathobiology and the Medical Director of Infection Prevention and Control (IPAC) at Sinai Health. Her research interests include preventing healthcare-associated infections from known and emerging pathogens with more than 125 peer-reviewed publications. She has participated widely in the development of clinical guidelines on topics such as COVID-19 and other IPAC topics on behalf of the National Advisory Committee on Infection Prevention and Control for Public Health Agency of Canada, Ontario Provincial Infectious Diseases Advisory Committee (PIDAC) and Ontario Health Toronto Region working groups. She is the current Chair of the Public Health Agency of Canada’s National Advisory of IPAC.
Kim, John
Dr. John Kim is the Chief of the Canadian government’s National HIV Reference Services (NLHRS) Laboratory at the National Microbiology Laboratory’s JCWilt Infectious Disease Center in Winnipeg, MB. Since 2015, they have engaged with Indigenous populations in Canada comprised of First Nations and Metis communities to increase access to testing opportunities for STBBI infections using dried blood spots. This novel intervention uses a model of engagement and ownership to encourage community uptake and empower these communities to undertake testing to ensure that it will be delivered in a culturally safe manner that is respectful of their traditions and values.
Kimberlin, David
Dr. David Kimberlin holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases at the University of Alabama at Birmingham, where he is Vice Chair for Clinical and Translational Research and Co-Director of the Division of Pediatric Infectious Diseases. Dr. Kimberlin is Editor of the 2024 American Academy of Pediatrics (AAP) Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2021, 2018, and 2015 editions. Dr. Kimberlin also is Editor-in-Chief of Long’s Principles and Practice of Pediatric Infectious Diseases, which is the leading textbook in the field. Since 2007, Dr. Kimberlin has served as the AAP Red Book liaison to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). He also is the Principal Investigator for the Collaborative Antiviral Study Group (CASG), now known as the Congenital and Perinatal Infections Consortium (CPIC). Dr. Kimberlin is a Past-President of the Pediatric Infectious Diseases Society, and in 2022 received the Walter T. Hughes Pediatric Infectious Diseases Society Distinguished Physician Award. In 2016 he received the Ronald McDonald House Charities 2016 Medical Award of Excellence. He has received numerous education awards.
Krajden, Mel
Mel Krajden O.B.C., MD, FRCPC is the former Medical Director of the BC Centre for Disease Control (BCCDC) Public Health Laboratory, and Medical Head of Hepatitis at the BCCDC. He is now a Microbiologist, Special Projects at the BCCDC. He is also a Professor of Pathology and Laboratory Medicine at the University of British Columbia. He was a Co-applicant on the $6.8 M Canadian Institutes of Health Research (CIHR) funded HPV “FOCAL Trial” which was designed to determine if primary HPV testing can replace Pap and/or co-testing as a screening modality. He oversaw the HPV DNA, mRNA, and genotyping testing assays that were used during the FOCAL trial. He has extensive clinical trials expertise and has received CIHR and/or other peer reviewed funding in the fields of human papillomavirus, HIV, hepatitis C virus, and COVID-19. He was also a Co-PI/Mentor for CIHR funded Canadian Hepatitis C Network (CanHepC) and has more than 360 publications.
Kuhn, Susan
Dr. Susan Kuhn is a pediatric infectious disease specialist in Calgary, where her clinical and academic focus has been on tropical medicine and migrant health. Her research and educational interests have expanded in recent years to encompass medical humanism, professional fulfillment, and faculty development. These interests fueled a sabbatical that resulted in the conceptual framework that is driving the development of a comprehensive faculty development program that is rooted in meaningful work. She enjoys making out-of-the-box ideas a reality, especially when she can find others to collaborate with to make them even better.
Lavallee, Christian
Dr Christian Lavallée completed his medical degree at the Université de Montréal in 2005. In 2010, he received his medical microbiology and infectiology certificate from the Collège des Médecins du Québec. In 2010, he completed one year of training on the detection of resistance in Gram-negative bacilli at the Health Protection Agency in the United Kingdom under the supervision of Dr. David Livermore and Dr. Neal Woodford. He completed in 2014 a Masters degree in epidemiology from the London School of Hygiene and Tropical Medicine. Dr Lavallée has been Head of the Division of Medical Microbiology and Infectious Diseases at Hôpital Maisonneuve-Rosemont from 2016 to 2021 and head of the division of medical microbiology at the grappe Optilab Montréal-CHUM since 2020. Since February 2022, he is the medical director of the grappe Optilab Montréal-CHUM. He is a clinical associate professor at the department of microbiology, infectiology and immunology at the Université de Montréal.
Le Saux, Nicole
Currently a Professor at the University of Ottawa in the Division of Infectious Disease at the Children’s Hospital of Eastern Ontario. She is the Medical Director of Antimicrobial Stewardship at CHEO. She has a Royal College Fellowships in Internal Medicine, Infectious diseases and Anatomic Pathology. She is curious about almost everything in Infectious Diseases, is a keen clinician, and has been covertly and overtly has been an advocate for less antibiotics even before stewardship became a buzzword.
Leifso, Kirk
Dr. Leifso earned his medical degree from the University of Calgary School of Medicine in 2008. Following this, he completed his residency in Pediatrics and further specialized in Pediatric Infectious Diseases at the University of Ottawa and the Children's Hospital of Eastern Ontario. Upon completing his training in 2014, he joined the Department of Pediatrics at Queen's University and the Kingston Health Sciences Centre. Dr. Leifso, in addition to his clinical responsibilities, serves as an Assistant Professor of Pediatrics and has been overseeing the Pediatric Residency Program at Queen's University since 2016. As Kingston's sole Pediatric Infectious Diseases consultant, Dr. Leifso views himself as a 'generalist specialist,' managing a wide-ranging clinical practice that encompasses inpatient and outpatient consultations for a variety of conditions, including complex and chronic infections, infections in immunocompromised individuals, evaluations for recurrent infections, as well as perinatal and congenital infections. Outside of his professional commitments, Dr. Leifso values the moments spent with his family hiking, canoing, and camping, and with his garage band friends playing the banjo as an enthusiastic amateur.
Leung, Victor
Dr. Leung trained in Infectious Diseases and Medical Microbiology at McGill University. He is currently the Medical Director of Infection Prevention and Control and the Medical Lead for Antimicrobial Stewardship at Providence Health Care.
Libman, Michael
Michael Libman is certified in Infectious Diseases and Medical Microbiology. He has had an interest in Tropical and Travel Medicine from the start of his career. He is currently the Director of the J.D. MacLean Centre for Tropical Medicine at McGill University, and Professor of Medicine at McGill. He is also chair of the Committee to Advise on Tropical Medicine and Travel (CATMAT) for the Public Health Agency of Canada, and the PI of the GeoSentinel Network, a project focused on surveillance of and research on the movement of infections across international borders.
Loeb, Mark
Dr. Mark Loeb is a Professor in the Departments of Pathology of Molecular Medicine and Health Research, Evidence, and Impact (formerly Clinical Epidemiology and Biostatistics) at McMaster University. Dr. Loeb holds the Canada Research Chair in Infectious Diseases and is Co-Director of the McMaster WHO Collaborating Centre on Infectious Diseases, Research Methods and Recommendations. He has conducted randomized controlled trials for the prevention of respiratory viral infection for the past 20 years, including of cluster randomized trials of influenza vaccine in children to examine herd immunity, influenza vaccine to reduce adverse vascular events. Recognitions have included the Gold Medal in Medicine from the Royal College of Physicians and Surgeons of Canada for research, Society for Healthcare Epidemiology of America Investigator Award, and the Jonas Salk award from the March of Dimes for research contributions, and Fellow ship in the Canadian Academy of Health Sciences. Dr. Loeb is a Fellow of the Royal Society of Canada.
Ma, Angela
Angela Ma is a Clinical Microbiologist at Public Health Ontario overseeing the Mycobacteriology portfolio. She is a certified medical laboratory technologist and holds a PhD in Laboratory Medicine and Pathology with Specialization in Molecular Pathology from the University of Alberta (2021). Dr. Ma completed a CPEP fellowship in Medical and Public Health Laboratory Microbiology at the University of Utah and ARUP Laboratories in 2023, and is a diplomat of the American Board of Medical Microbiology and Fellow of the Canadian College of Microbiologists. In her role as a Clinical Microbiologist, Dr. Ma provides technical and scientific guidance on diagnostic testing of mycobacterial infections, outbreak investigation, and surveillance of tuberculosis. Her research interests include molecular diagnostics and epidemiology, antimicrobial resistance, and applications for next generation sequencing to support microbiology diagnostics and public health surveillance efforts.
Mah, Allison
Allison completed medical school and internal medicine training at the University of Alberta followed by subspecialty infectious diseases training at UBC. She trained in transplant ID at the University of Texas - MD Anderson Cancer Center with a focus on infectious complications of stem cell transplantation. She currently works at Vancouver General Hospital as a transplant infectious disease physician and is the UBC adult ID training program director and transplant ID fellowship director.
McGeer, Allison
Dr. McGeer is a professor of Laboratory Medicine and Pathobiology, and the Dalla Lana School of Public Health at the University of Toronto, a Senior Clinician Scientist, Lunenfeld-Tanenbaum Research Institute, and an adult infectious disease physician at Sinai Health. She is the coordinating investigator of TIBDN, a surveillance network that has been performed population-based surveillance for invasive pneumococcal disease and influenza and RSV-associated hospitalization in southern Ontario. She is currently a member of NACI’s influenza and pneumococcal working groups, and of the Ontario Immunization Advisory Committee, and an advocate for creating adult immunization programs that work as well as our pediatric programs.
Morris, Andrew
Dr. Andrew Morris is an Infectious Diseases Consultant and Professor of Medicine at Sinai Health, University Health Network, and the University of Toronto. He led the Sinai Health-University Health Network Antimicrobial Stewardship Program since its founding in February 2009 until March 2024. He is an internationally recognized expert in antimicrobial stewardship and previously chaired both AMMI Canada and SHEA's Antimicrobial Stewardship and Resistance Committees, and most recently Chaired the Council of Canadian Academies Expert Panel Report "Overcoming Resistance".
Nguyen, Lananh
Lananh Nguyen, MD MSc is a Diplomate of the American Board of the Pathology in Cytopathology and is the Medical Director of Cytopathology at Unity Health Toronto Hospitals in Toronto. Her research interests focuses on quality assurance practices and quality improvement in cytology laboratories.
Peermohamed, Shaqil
Dr. Shaqil Peermohamed completed his fellowship in Infectious Diseases at the University of Toronto in 2016. He began his career with the Saskatchewan Health Authority and University of Saskatchewan as an Infectious Disease consultant and Physician Lead of antimicrobial stewardship in Saskatoon. In 2023, Dr. Peermohamed embarked upon the next phase of his career, moving to Vancouver, BC and is currently an Infectious Disease consultant with Vancouver Coastal Health and Regional Medical Director of ASPIRES. He completed his Master of Public Health through the Harvard T.H. Chan School of Public Health, focusing on clinical effectiveness. Building on his outstanding teaching awards and honours list, Dr. Peermohamed is also completing his Clinical Educator Diploma through the Royal College of Physicians and Surgeons of Canada. In his spare time, Dr. Peermohamed enjoys tabletop games, paddleboarding, and escape rooms.
Peto, Ben
Ben is a transgender Patient Experience Advisor at Women's College Hospital. He holds an MA in Sociology and Equity Studies from OISE/UT.
Plewes, Katherine
Dr. Katherine Plewes is an Adult Infectious Diseases specialist, Clinical Assistant Professor at UBC and Honorary Visiting Research Fellow in Tropical Medicine, University of Oxford, with research interests in malaria and tropical diseases. She completed the UBC Clinical Investigator Program and a DPhil in Clinical Medicine at the University of Oxford focused on the pathophysiology and treatment of severe malaria. She continues to work with an international and multidisciplinary team at the Mahidol Oxford Research Unit located in Bangkok, Thailand, focused on the pathophysiology and treatment of severe malaria, and management of sepsis with antimicrobial stewardship in low- and middle-income settings. She has extensive field experience, currently working on active projects in Bangladesh and the Democratic Republic of the Congo. In 2019, Dr. Plewes was awarded a 3-year CIHR Project Grant and MSFHR Health Professional-Investigator award to assess the renoprotective role of acetaminophen in severe pediatric malaria. She is Vancouver Site Lead for the GeoSentinel Surveillance Network, a global network that conducts surveillance of emerging infectious diseases using returning travelers as sentinels of infection. She also represents BC as a committee member and Malaria Subcommittee chair to the Public Health Agency of Canada (PHAC) Canadian Advisory on Tropical Medicine and Travel (CATMAT), and designate BC physician to the PHAC Canadian Malaria Network (CMN). Recent work is focused on collaborating nationally towards creating a Canadian Echinococcosis Registry with colleagues across the country.
Potter, Emery
Emery Potter NP-PHC, BScN, MN (they/them) is a non-binary nurse practitioner in the Transition Related Surgery Program at Women's College Hospital and an adjunct lecturer at the Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto. Emery's work in over the last decade has focused on a diverse range of clinical issues and research topics including: HIV, mental health, harm reduction, mobile health, hepatitis C and 2SLGBTQIA+ health. Emery has provided primary care to hundreds of trans, non-binary and gender diverse individuals including the provision of hormone therapy and pre and postoperative surgical care. Emery has played an essential role in building clinical competencies in trans health across Ontario through the development and implementation of curriculum, training, seminars, and programs. Emery is currently engaged in multiple interdisciplinary and collaborative research projects focused on aspects of transition related surgery such as surgical access, quality improvement, patient reported and post-operative outcomes, pain and the vaginal microbiome. Through research, they hope to better understand the current gaps related to transition related surgery, integrating knowledge gained into clinical care and advocating for broader systemic and policy change.
Proctor, Lily
Dr. Lily Proctor is a surgical gynecologic oncologist at the BC Cancer Agency and at Vancouver General Hospital. She is the medical director of BC Cancer's Cervical cancer screening program and serves as the Provincial cervical cancer colposcopy lead. She obtained her Fellowship in Gynecologic Oncology at UBC followed by a Masters in Clinical Epidemiology and Public Health at the Harvard T.H Chan School of Public Health.
Prodger, Jessica
Dr. Jessica Prodger is an Assistant Professor of Microbiology and Immunology and Director of the Global Health Systems Master of Health Sciences (MHSc) program at Western University in Ontario, Canada. She received her PhD from the University of Toronto and completed Postdoctoral Fellowships at the Johns Hopkins School of Public Health and at the Laboratory for Immunoregulation at the National Institutes of Health. She holds a Tier II Canada Research Chair in Genital Immunology and STI Prevention and her research program at Western focuses on understanding how genital microbiota influence local host immune responses and thus susceptibility to pathogenic genital infections.
Rasmussen, Angela
Dr. Angela (Angie) Rasmussen, PhD is a virologist at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan. Her research focuses on the role of the host in virus susceptibility and pathogenesis, with a particular interest in emerging viruses that are or have the potential to be major threats to global health, such as avian influenza virus, dengue virus, Ebola virus, mpox (monkeypox) virus, MERS-CoV, and SARS-CoV-2. Dr. Rasmussen graduated from Smith College with a BA in Biological Sciences (2000) and received a MA (2005), MPhil (2006), and PhD (2009) in Microbiology and Immunology from Columbia University. She did her postdoctoral fellowship at the University of Washington and previously held faculty positions at the University of Washington and the Columbia Mailman School of Public Health, as well as an affiliation with the Georgetown Center for Global Health Science and Security. In addition to her primary appointment at VIDO, Angie is also an adjunct professor in the Department of Biochemistry, Microbiology, and Immunology at the University of Saskatchewan and an adjunct professor in the Department of Ecology and Evolution at Stony Brook University. She is the co-lead of the Coronavirus Variants Rapid Response Network (CoVaRR-Net) Host-Virus Interactions pillar. She is also a member of the WHO Ad Hoc Expert Committee for Preclinical Models of COVID-19 and sits on the Editorial Boards at Vaccine, mSphere, and Cell Reports. In addition to her research, Dr. Rasmussen is a prolific science communicator on both social media and in the mainstream press, as well as a writer for numerous publications including Forbes, Leaps.org, Slate, Foreign Affairs, the Washington Post, and the New York Times. She is passionate about advocating for equity in biomedical research and public health, and is a member of the US NIH Advisory Committee to the Director Working Group on Changing the Culture to End Sexual Harassment, as well as a faculty mentor for the volunteer science education group Wearing is Caring. She believes strongly that biosecurity and global public health must be collaborative international efforts and is eager to extend this outreach work in Canada and abroad.
Sakoulas, George
Dr. George Sakoulas is an active infectious disease clinician in the Sharp Healthcare System, San Diego, CA and chief of infectious diseases of the Sharp Rees-Stealy Medical Group. He is also an Adjunct Professor in the Division of Host-Microbe Systems and Therapeutics, Center for Immunity, Infection and Inflammation at the University of California San Diego School of Medicine. He has been practicing clinical infectious disease for over 20 years. Dr. Sakoulas received his undergraduate degree from Columbia University and his medical degree from Harvard Medical School. He completed his clinical training in internal medicine and infectious diseases at the Beth Israel Deaconess Medical Center in Boston. Through studying the relationships between antimicrobial resistance and bacterial virulence and the interactions between innate host defense and administered antibiotics, Dr. Sakoulas is working towards developing more effective contemporary therapies for common severe infections by utilizing available drugs. This includes the repurposing of medications used for other diseases as well as with combination antibiotic therapies aimed at virulence attenuation in addition to conventional direct antibacterial effects. By harnessing the cooperativity of some antibiotics with the innate immune response as well as favorable pharmacokinetic properties of antibiotics, Dr. Sakoulas is developing strategies to streamline the therapeutics of infections for the benefit of the patient and healthcare systems.
Saxinger, Lynora
Dr. Saxinger is an Infectious Diseases specialist physician and Professor at the University of Alberta, with a focus on antimicrobial stewardship and antibiotic resistance and utilization surveillance. Early in the pandemic she became engaged in traditional media (over 2500 interviews) and social media (predominantly Twitter) in an effort to counter misinformation. This informs her evolving professional work in disinformation, knowledge translation and science communication to the public.
Schwartz, Kevin
Dr. Kevin Schwartz is the division head for infectious diseases at St. Joseph's Health Centre in Toronto and co-medical director for antimicrobial stewardship at Unity Health Toronto. He is an academic infection control and antimicrobial stewardship physician at Public Health Ontario, an assistant professor at the Dalla Lana School of Public Health at the University of Toronto, and an adjunct scientist at ICES. His clinical area of interest is adult and pediatric infectious diseases and tropical medicine. His research interests include vaccine preventable diseases and antimicrobial stewardship with a particular focus on improving community antibiotic use to slow the emergence of drug resistant infections.
Silverman, Michael
Dr. Silverman received his medical degree and Residency in Internal Medicine at the University of Toronto. He carried out his fellowship in Infectious Diseases at the University of Manitoba in Winnipeg, and an HIV post-doctoral fellowship at the University of California, San Francisco, USA. He is Chair/Chief and Professor of Medicine and Infectious Diseases at Western University. Dr. Silverman is a pioneer in the field of Fecal Microbial Transplantation (FMT) for treatment of Clostridium difficile. He was one of the first to perform the procedure in North America and he has established a large clinical and research program associated with this. He was also the first to demonstrate the effectiveness of FMT in first line therapy of cancer patients on immunotherapy. He has conducted many studies of prevention of infectious complications of injection drug use and has worked extensively in developing countries doing research on HIV and Tropical Infections. He has over 150 peer reviewed publications including recently as a first or senior author in the Annals of Internal Medicine, New England Journal of Medicine, Nature Medicine, JAMA series and Lancet Infectious Diseases. Reviews of his work have been written in Science, Nature and reported in the international mass media including in the New York Times, BBC, CNN, The Times of India, etc.
Szwajcer, David
David Szwajcer is a practicing hematologist in Winnipeg, Manitoba. He functions as the Manitoba Blood and Marrow Transplant Program Director. He is involved in the treatment of patients with complex hematological malignancies using a variety of cellular immunotherapy.
Tam, Ed
Dr. Edward Tam, MD, FRCPC, is a clinical hepatologist in Vancouver, BC. He is active in clinical research, teaching, and clinical care in general outpatient hepatology. He has published extensively in high impact journals and contributed to clinical practice guidelines in the field. Dr. Tam serves as Secretary/Treasurer to the CASL Executive (Canadian Association for the Study of the Liver) and is also a longstanding volunteer board member with the Canadian Liver Foundation BC/Yukon region.
Tam, Jennifer
Dr. Jennifer Tam is a pediatric infectious diseases physician practicing at BC Children’s Hospital in Vancouver, BC. She has been the pediatric infectious diseases subspecialty training program director since 2018. She completed her medical school at the University of British Columbia (UBC), and her pediatric residency and subspecialty training at the Hospital for Sick Children in Toronto. She obtained her Master of Health Professions Education (MHPE) from Maastricht University in partnership with the Centre for Health Education Scholarship at UBC in 2019. When not working, her time is mostly occupied by her 1-year-old son and 3-year-old daughter, reality TV shows, and exploring the Vancouver food scene.
Tran, Vanessa
Dr. Vanessa Tran is a Clinical Microbiologist at Public Health Ontario (PHO) and an Assistant Professor at the University of Toronto. At PHO, she leads the STBBI laboratory portfolio, including testing for HIV, hepatitis viruses, and bacterial STIs. She has led the resident education and professional education portfolios, where she was responsible for program planning and supervision of trainees. She also led COVID-19 serology testing, contributing to several provincial and national serosurveillance studies. Vanessa completed her BSc at the University of Guelph, PhD at the University of Toronto, and Clinical Microbiology Fellowship at the University of Manitoba. She has experience working in hospital, community, and public health microbiology laboratories. Vanessa’s broad areas of interest include molecular diagnostics and molecular epidemiology of infectious diseases of public health significance, particularly the STBBIs.
Tyrrell, Greg
Dr. Tyrrell is a Clinical Microbiologist at the Alberta Provincial Laboratory for Public Health and Professor in the Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta. He did his undergraduate education at the University of Alberta and a PhD degree and Clinical Microbiology Fellowship at the University of Toronto. Subsequently he worked for two years at Dalhousie University in Halifax as a Clinical Microbiologist before returning to the University of Alberta where he is currently located. He has a strong interest in group A and group B streptococci as well as Streptococcus pneumoniae and has worked in the field of streptococci for many years. His interests lie in both the epidemiological aspects of streptococci as well as virulence properties associated with these bacteria.
Waldner, David
Ward, Brian
Dr. Ward received training in Infectious Diseases, Microbiology & Tropical Medicine at McGill University, Oxford University, University of London and Johns Hopkins. He is currently a professor at McGill (1991-present). Since 1991, he has served on many Provincial, National and international advisory committee related to vaccines including the CIHR Institutional Advisory Board for the Institute of Infection & Immunity (chair 2014-2021). Dr Ward is also adjunct faculty at Cayetano Heredia University in Lima, Peru. Throughout his career, he has had close ties with vaccine manufacturers including serving as Medicago's Chief Medical Officer (2017-2023) where he helped license the world’s first vaccine produced in plants (February 2022). His research interests include novel vaccines and adjuvants. He has received a number of awards including a Rhodes scholarship (1977), the US Secretary of Defense Exceptional Public Service Award (2003) and the Quebec Innovation Prize for vaccine development (2020). He has published more than 310 manuscripts and is a fellow of the Canadian Academy of Health Sciences.
Weaver, Victoria
Dr. Victoria Weaver is an adult infectious diseases and addiction medicine physician in Vancouver, British Columbia, and a Clinical Assistant Professor in the Department of Medicine at the University of British Columbia. She trained in internal medicine at the University of Calgary before completing her adult infectious diseases fellowship and addiction medicine training at the University of British Columbia. She currently works as an adult ID physician at Vancouver General Hospital and as an addiction medicine physician at St. Paul's Hospital.
Adalja, Amesh
Dr. Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health, and an Affiliate of the Johns Hopkins Center for Global Health. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. He actively practices infectious disease, critical care, and emergency medicine in the Pittsburgh metropolitan area.
Airo, Adriana
Adriana Airo is a Clinical Microbiologist and Program Head for the High Volume Serology Laboratory at the BC Centre for Disease Control. She is a Fellow of the Canadian College of Microbiologists who recently completed her Clinical Microbiology training at the University of Toronto in 2023. Prior to that, she completed her Bachelor of Science in Microbiology and Immunology from the University of British Columbia and her doctoral studies in Virology in the Department of Medical Microbiology & Immunology at the University of Alberta. In her PhD, she focused on elucidating the molecular mechanisms by which arboviruses such as Dengue and Zika viruses hijack cellular pathways and cause disease. Her areas of interest include viral hepatitis, emerging viral pathogens and zoonotic diseases.
Alexander, David
Dr. David Alexander is a PhD-trained microbiologist with a long-standing interest in the application of genomic technologies to infectious diseases. For the past 17 years, he has worked in the provincial public health laboratory system, first at the Public Health Ontario Laboratories in Toronto, then at the Saskatchewan Disease Control Laboratory in Regina. Since 2016, David has been a Scientist at the Cadham Provincial Laboratory. He provides support for assay validation and research activities and is actively involved with genomic surveillance of bacterial pathogens that cause foodborne illness and sexually transmitted infections.
Banerji, Versha
Dr. Versha Banerji, MD FRCPC obtained her MD and residency training in Internal Medicine and Hematology at the University of Manitoba. She then completed a post-doctoral fellowship in translational research at the Harvard Cancer Centre/ Dana-Farber Cancer Institute and Broad Institute of MIT. She is a Senior Scientist at the Paul Albrechtsen CancerCare Manitoba Research Institute, Associate Professor at the University of Manitoba, and a Clinician-Scientist at CancerCare Manitoba. She is the inaugural Director of the Chronic Lymphocytic Leukemia, Clinical Care, Education and Translational Research Unit at the University of Manitoba and CCMB and leads clinical trials and population-based treatment studies locally. She manages a multi-disciplinary research team in clinical, fundamental and translational research and is the principle investigator for local, national and international clinical trials at CancerCare Manitoba. Her own laboratory is evaluating novel therapeutics and the impact on mitochondrial function and metabolism.
Bogoch, Isaac
Dr. Isaac Bogoch is an Associate Professor at the University of Toronto in the Department of Medicine, and an Infectious Diseases specialist at the Toronto General Hospital with a focus on tropical diseases, HIV, and general infectious diseases. Dr. Bogoch works at the intersection of clinical medicine, epidemiology, public health, and policy. He divides his clinical and research time between Toronto and several countries in Africa and Asia. He collaborates with a team that models the spread of emerging tropical infectious diseases, and studies innovative and simple diagnostic solutions to improve the quality of medical care in low-resource settings.
Chagla, Zain
Dr. Chagla is an Associate Professor at McMaster University, and an Infectious Diseases Consultant. He is Medical Director of Infection Control, Head of Infectious Diseases Service, and Interim Senior Medical Director of Clinical Operations at St Joseph’s Healthcare Hamilton. He is a member of the Institute for Infectious Diseases Research (IIDR) at McMaster University, and a board director of AMMI-Canada (Association of Medical Microbiology and Infectious Diseases). Dr. Chagla holds a BSc and MD from Queen’s University, an Internal Medicine Residency from Western University, an Infectious Diseases Fellowship at McMaster University, and a Masters of Science (Infectious Diseases), and Diploma in Tropical Medicine from the London School of Hygiene and Tropical medicine.
Charles, Marthe
Dr. Charles has a MD MSc degree from Université de Montreal since 2010. She has completed her residency in Medical Microbiology and Infectious Diseases at University of Alberta in 2016. Now Division Head of the Medical Microbiology and Infection Prevention and Control at Vancouver Coastal Health for the last 7 years, her interest lays in more integrated diagnostics, increasing access and quality improvement. She currently oversees urogenital infections and molecular diagnostic at VCH. From an IPAC perspective, she is involved in laboratory assessment of self-disinfecting surfaces.
Chorlton, Sam
Sam Chorlton is a board-certified medical microbiologist and CEO of BugSeq Bioinformatics. After medical school at McMaster, Sam completed microbiology residency at the University of British Columbia. Sam then founded BugSeq Bioinformatics, a sequencing analysis company for clinical and public health labs. In this capacity, he oversees analysis for over 700 laboratories, including hospital, state and national labs. He has served as PI or investigator on projects for the US CDC and BARDA, including the development of rapid metagenomic and biothreat sequencing assays.
Chu, Angel
Angel Chu is an Infectious Diseases Physician, Clinical Assistant Professor, Cumming School of Medicine, and Medical Director, Calgary STI Clinic. She is also the former Vice-Chair of Immunize Canada.
Comeau, Jeannette
Dr. Jeannette Comeau is an Assistant Professor of Pediatrics at Dalhousie University and Pediatric Infectious Diseases Physician at IWK Health Centre in Halifax, NS. After completing her Doctor of Medicine at Dalhousie University, she went on to complete residency in Pediatrics and Paediatric Infectious Diseases both at McGill University. Prior returning home to Halifax, she completed a fellowship in Vaccinology at the National Centre for Immunisation Research & Surveillance, Sydney, Australia. In addition to her clinical responsibilities, Dr. Comeau is the Medical Director, Infection Prevention and Control, and the Medical Lead, Antimicrobial Stewardship at the IWK Health Centre. She is also an investigator at the Canadian Centre for Vaccinology focusing on vaccine policy, safety and hesitancy.
Constantinescu, Cora
Cora Constantinescu is a pediatrician, infectious disease physician and clinical associate professor in Calgary, AB. From seeing vaccine hesitant patients in clinic, to her academic pursuits in vaccine acceptance and surveillance, she has a strong passion for vaccine research and promotion. She holds a Masters in Medical Education and specializes in development and study of education interventions rooted in behavioral change theory. She has applied these skills to vaccine education for healthcare workers and the public and continues to be a vaccine advocate at the local and national levels.
Descamps, Philippe
Philippe Descamps is a Professor of Obstetrics and Gynaecology and has been Head of the Department in Obstetrics and Gynecology at the Angers University Hospital in Angers, France since 1999. In addition, he is the Director of the regional reference center for endometriosis, Endo Ref-Pays de Loire. Professor Descamps has been the FIGO Vice-President from 2021 until 2023 and a member of the FIGO Strategic Planning Committee since 2021 after having been elected as the French representative to the FIGO Council from 2015 to 2021. At a national level, he is President of the International Relations Committee and a member of both the Board and the Bureau of the French National College of Gynecologists and Obstetricians. He previously served as Vice-President of the French Society of Gynecological and Pelvic Surgery from 2011 to 2021. Professor Descamps’ clinical and surgical expertise in Obstetrics and Gynecology include endometriosis, and pelvic cancers.
Dionne, Kim
Kim Dionne is the Manager of Laboratory Services at Qikiqtani General Hospital in Iqaluit, NU. She received her educated at Algonquin College in Ottawa and worked as a generalist lab tech for 13 years before spending 5 years working in various locations in the Middle East. She worked for 17 years in the AFB lab at Johns Hopkins in Baltimore, MD before finally returning to Canada in 2019 to take the position at QGH.
Feld, Jordan
Dr. Feld is a Professor of Medicine at the University of Toronto, Ontario, Canada. He trained in GI and Hepatology at the University of Toronto and did post-doctoral training in the Liver Diseases Branch at the National Institutes of Health in laboratory and clinical research in viral hepatitis. After completing a Masters in Public Health at the Johns Hopkins Bloomberg School of Public Health, he returned to Toronto. He is a Professor of Medicine at the University of Toronto and holds the R. Phelan Chair in Translational Liver Research as a clinician-scientist at the Toronto Centre for Liver Disease in the Toronto General Hospital where he leads a large clinical and translational research program focused primarily on viral hepatitis and its complications.
Gin, Alfred
Alfred Gin obtained his BScPharm undergraduate degree from the University of Manitoba and his PharmD at University of Buffalo. He is an Infectious Diseases Clinical Pharmacist at the Health Sciences Centre Winnipeg with over 30 years of I.D. experience working closely with the Section of Infectious Diseases. Alfred has a cross-appointment as an Assistant Professor with the Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba. Alfred has a keen interest in optimizing antimicrobial use and approaching questions from a broader clinical perspective. He is active on many professional committees, working groups and organizations. He enjoys problem solving challenges and technology.
Glassman, Heather
Heather Glassman is a Medical Microbiologist and Infection Prevention and Control physician at Vancouver General Hospital. She is a Clinical Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia. She completed her medical degree and Medical Microbiology residency training at the University of Alberta.
Goldfarb, David
David Goldfarb is a Medical Microbiologist and Pediatric Infectious Disease specialist based at BC Children’s Hospital and BC Women’s Hospital + Health Centre where he also serves as the Associate Head of the Department of Pathology and Laboratory Medicine. Dr. Goldfarb had completed his training and certification in Pediatrics, Infectious Diseases and Medical Microbiology at the University of Ottawa. Prior to coming to UBC, he had academic appoints at McMaster University and the University of Botswana. Dr. Goldfarb’s research focuses primarily on novel diagnostic, management and prevention strategies for pediatric infectious diseases, particularly in resource limited settings.
Grant, Jennifer
Dr. Jennifer Grant trained in Medicine, Infectious Diseases and Medical Microbiology at McGill and has practiced Microbiology and Infectious Diseases in Vancouver since 2007. She has represented both CHICA (now IPAC) and AMMI Canada as a board member, and is now the program head for bacteriology and mycology at BCCDC with an interest in health systems, antimicrobial stewardship and quality of patient care. Away from medicine, Jennifer is mother to Sierra, Alexis and Océanne, and avid skier and mountain biker, making use of the coastal mountains whenever possible.
Hanomansing, Ian
Ian Hanomansing was born in Port-of-Spain, Trinidad, and grew up in Sackville, New Brunswick. He graduated with an honours B.A. in political science and sociology from Mount Allison University in Sackville and has a law degree from Dalhousie University in Halifax. He began his broadcasting career at CKDH Radio in Amherst, Nova Scotia, working at radio stations in Moncton and Halifax before joining CBC in Halifax in 1986. His assignments took him to Toronto the following year and eventually to Vancouver, where he was a national reporter for fourteen years. He hosts the CBC News' flagship program THE NATIONAL from Vancouver on Fridays and Sundays, and is also the host of CROSS COUNTRY CHECKUP on CBC Radio and CBC News Network
Hatchette, Todd
Dr. Hatchette is a Medical Microbiologist and Infectious disease physician who is the Chief of Service for the Division of Microbiology, QEII Health Science Center and the Co-Director of the Virology and Immunology. He is a Professor in the Department of Pathology with a cross-appointments in the Departments of Immunology and Microbiology and Medicine where he is a consultant Infectious Diseases. In addition, Dr. Hatchette is the past President of the Association of Medical Microbiology and infectious Diseases (AMMI) Canada.
Isabel, Sandra
Johnstone, Jennie
Dr. Johnstone obtained her medical degree from Dalhousie University. She then moved to Edmonton, Alberta where she completed her Internal Medicine and Infectious Disease training at the University of Alberta. Following her residency, she completed a clinical research fellowship in Edmonton and subsequently, completed her PhD in Health Research Methodology (Epidemiology) at McMaster University. Dr. Johnstone is currently the Division Head of Infectious Diseases at the University of Toronto, is an Associate Professor in the Departments of Medicine and Laboratory Medicine and Pathobiology and the Medical Director of Infection Prevention and Control (IPAC) at Sinai Health. Her research interests include preventing healthcare-associated infections from known and emerging pathogens with more than 125 peer-reviewed publications. She has participated widely in the development of clinical guidelines on topics such as COVID-19 and other IPAC topics on behalf of the National Advisory Committee on Infection Prevention and Control for Public Health Agency of Canada, Ontario Provincial Infectious Diseases Advisory Committee (PIDAC) and Ontario Health Toronto Region working groups. She is the current Chair of the Public Health Agency of Canada’s National Advisory of IPAC.
Kim, John
Dr. John Kim is the Chief of the Canadian government’s National HIV Reference Services (NLHRS) Laboratory at the National Microbiology Laboratory’s JCWilt Infectious Disease Center in Winnipeg, MB. Since 2015, they have engaged with Indigenous populations in Canada comprised of First Nations and Metis communities to increase access to testing opportunities for STBBI infections using dried blood spots. This novel intervention uses a model of engagement and ownership to encourage community uptake and empower these communities to undertake testing to ensure that it will be delivered in a culturally safe manner that is respectful of their traditions and values.
Kimberlin, David
Dr. David Kimberlin holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases at the University of Alabama at Birmingham, where he is Vice Chair for Clinical and Translational Research and Co-Director of the Division of Pediatric Infectious Diseases. Dr. Kimberlin is Editor of the 2024 American Academy of Pediatrics (AAP) Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2021, 2018, and 2015 editions. Dr. Kimberlin also is Editor-in-Chief of Long’s Principles and Practice of Pediatric Infectious Diseases, which is the leading textbook in the field. Since 2007, Dr. Kimberlin has served as the AAP Red Book liaison to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). He also is the Principal Investigator for the Collaborative Antiviral Study Group (CASG), now known as the Congenital and Perinatal Infections Consortium (CPIC). Dr. Kimberlin is a Past-President of the Pediatric Infectious Diseases Society, and in 2022 received the Walter T. Hughes Pediatric Infectious Diseases Society Distinguished Physician Award. In 2016 he received the Ronald McDonald House Charities 2016 Medical Award of Excellence. He has received numerous education awards.
Krajden, Mel
Mel Krajden O.B.C., MD, FRCPC is the former Medical Director of the BC Centre for Disease Control (BCCDC) Public Health Laboratory, and Medical Head of Hepatitis at the BCCDC. He is now a Microbiologist, Special Projects at the BCCDC. He is also a Professor of Pathology and Laboratory Medicine at the University of British Columbia. He was a Co-applicant on the $6.8 M Canadian Institutes of Health Research (CIHR) funded HPV “FOCAL Trial” which was designed to determine if primary HPV testing can replace Pap and/or co-testing as a screening modality. He oversaw the HPV DNA, mRNA, and genotyping testing assays that were used during the FOCAL trial. He has extensive clinical trials expertise and has received CIHR and/or other peer reviewed funding in the fields of human papillomavirus, HIV, hepatitis C virus, and COVID-19. He was also a Co-PI/Mentor for CIHR funded Canadian Hepatitis C Network (CanHepC) and has more than 360 publications.
Kuhn, Susan
Dr. Susan Kuhn is a pediatric infectious disease specialist in Calgary, where her clinical and academic focus has been on tropical medicine and migrant health. Her research and educational interests have expanded in recent years to encompass medical humanism, professional fulfillment, and faculty development. These interests fueled a sabbatical that resulted in the conceptual framework that is driving the development of a comprehensive faculty development program that is rooted in meaningful work. She enjoys making out-of-the-box ideas a reality, especially when she can find others to collaborate with to make them even better.
Lavallee, Christian
Dr Christian Lavallée completed his medical degree at the Université de Montréal in 2005. In 2010, he received his medical microbiology and infectiology certificate from the Collège des Médecins du Québec. In 2010, he completed one year of training on the detection of resistance in Gram-negative bacilli at the Health Protection Agency in the United Kingdom under the supervision of Dr. David Livermore and Dr. Neal Woodford. He completed in 2014 a Masters degree in epidemiology from the London School of Hygiene and Tropical Medicine. Dr Lavallée has been Head of the Division of Medical Microbiology and Infectious Diseases at Hôpital Maisonneuve-Rosemont from 2016 to 2021 and head of the division of medical microbiology at the grappe Optilab Montréal-CHUM since 2020. Since February 2022, he is the medical director of the grappe Optilab Montréal-CHUM. He is a clinical associate professor at the department of microbiology, infectiology and immunology at the Université de Montréal.
Le Saux, Nicole
Currently a Professor at the University of Ottawa in the Division of Infectious Disease at the Children’s Hospital of Eastern Ontario. She is the Medical Director of Antimicrobial Stewardship at CHEO. She has a Royal College Fellowships in Internal Medicine, Infectious diseases and Anatomic Pathology. She is curious about almost everything in Infectious Diseases, is a keen clinician, and has been covertly and overtly has been an advocate for less antibiotics even before stewardship became a buzzword.
Leifso, Kirk
Leung, Victor
Dr. Leung trained in Infectious Diseases and Medical Microbiology at McGill University. He is currently the Medical Director of Infection Prevention and Control and the Medical Lead for Antimicrobial Stewardship at Providence Health Care.
Libman, Michael
Michael Libman is certified in Infectious Diseases and Medical Microbiology. He has had an interest in Tropical and Travel Medicine from the start of his career. He is currently the Director of the J.D. MacLean Centre for Tropical Medicine at McGill University, and Professor of Medicine at McGill. He is also chair of the Committee to Advise on Tropical Medicine and Travel (CATMAT) for the Public Health Agency of Canada, and the PI of the GeoSentinel Network, a project focused on surveillance of and research on the movement of infections across international borders.
Loeb, Mark
Dr. Mark Loeb is a Professor in the Departments of Pathology of Molecular Medicine and Health Research, Evidence, and Impact (formerly Clinical Epidemiology and Biostatistics) at McMaster University. Dr. Loeb holds the Canada Research Chair in Infectious Diseases and is Co-Director of the McMaster WHO Collaborating Centre on Infectious Diseases, Research Methods and Recommendations. He has conducted randomized controlled trials for the prevention of respiratory viral infection for the past 20 years, including of cluster randomized trials of influenza vaccine in children to examine herd immunity, influenza vaccine to reduce adverse vascular events. Recognitions have included the Gold Medal in Medicine from the Royal College of Physicians and Surgeons of Canada for research, Society for Healthcare Epidemiology of America Investigator Award, and the Jonas Salk award from the March of Dimes for research contributions, and Fellow ship in the Canadian Academy of Health Sciences. Dr. Loeb is a Fellow of the Royal Society of Canada.
Ma, Angela
Angela Ma is a Clinical Microbiologist at Public Health Ontario overseeing the Mycobacteriology portfolio. She is a certified medical laboratory technologist and holds a PhD in Laboratory Medicine and Pathology with Specialization in Molecular Pathology from the University of Alberta (2021). Dr. Ma completed a CPEP fellowship in Medical and Public Health Laboratory Microbiology at the University of Utah and ARUP Laboratories in 2023, and is a diplomat of the American Board of Medical Microbiology and Fellow of the Canadian College of Microbiologists. In her role as a Clinical Microbiologist, Dr. Ma provides technical and scientific guidance on diagnostic testing of mycobacterial infections, outbreak investigation, and surveillance of tuberculosis. Her research interests include molecular diagnostics and epidemiology, antimicrobial resistance, and applications for next generation sequencing to support microbiology diagnostics and public health surveillance efforts.
Mah, Allison
Allison completed medical school and internal medicine training at the University of Alberta followed by subspecialty infectious diseases training at UBC. She trained in transplant ID at the University of Texas - MD Anderson Cancer Center with a focus on infectious complications of stem cell transplantation. She currently works at Vancouver General Hospital as a transplant infectious disease physician and is the UBC adult ID training program director and transplant ID fellowship director.
McGeer, Allison
Dr. McGeer is a professor of Laboratory Medicine and Pathobiology, and the Dalla Lana School of Public Health at the University of Toronto, a Senior Clinician Scientist, Lunenfeld-Tanenbaum Research Institute, and an adult infectious disease physician at Sinai Health. She is the coordinating investigator of TIBDN, a surveillance network that has been performed population-based surveillance for invasive pneumococcal disease and influenza and RSV-associated hospitalization in southern Ontario. She is currently a member of NACI’s influenza and pneumococcal working groups, and of the Ontario Immunization Advisory Committee, and an advocate for creating adult immunization programs that work as well as our pediatric programs.
Morris, Andrew
Dr. Andrew Morris is an Infectious Diseases Consultant and Professor of Medicine at Sinai Health, University Health Network, and the University of Toronto. He led the Sinai Health-University Health Network Antimicrobial Stewardship Program since its founding in February 2009 until March 2024. He is an internationally recognized expert in antimicrobial stewardship and previously chaired both AMMI Canada and SHEA's Antimicrobial Stewardship and Resistance Committees, and most recently Chaired the Council of Canadian Academies Expert Panel Report "Overcoming Resistance".
Nguyen, Lananh
Lananh Nguyen, MD MSc is a Diplomate of the American Board of the Pathology in Cytopathology and is the Medical Director of Cytopathology at Unity Health Toronto Hospitals in Toronto. Her research interests focuses on quality assurance practices and quality improvement in cytology laboratories.
Peermohamed, Shaqil
Dr. Shaqil Peermohamed completed his fellowship in Infectious Diseases at the University of Toronto in 2016. He began his career with the Saskatchewan Health Authority and University of Saskatchewan as an Infectious Disease consultant and Physician Lead of antimicrobial stewardship in Saskatoon. In 2023, Dr. Peermohamed embarked upon the next phase of his career, moving to Vancouver, BC and is currently an Infectious Disease consultant with Vancouver Coastal Health and Regional Medical Director of ASPIRES. He completed his Master of Public Health through the Harvard T.H. Chan School of Public Health, focusing on clinical effectiveness. Building on his outstanding teaching awards and honours list, Dr. Peermohamed is also completing his Clinical Educator Diploma through the Royal College of Physicians and Surgeons of Canada. In his spare time, Dr. Peermohamed enjoys tabletop games, paddleboarding, and escape rooms.
Peto, Ben
Ben is a transgender Patient Experience Advisor at Women's College Hospital. He holds an MA in Sociology and Equity Studies from OISE/UT.
Plewes, Katherine
Dr. Katherine Plewes is an Adult Infectious Diseases specialist, Clinical Assistant Professor at UBC and Honorary Visiting Research Fellow in Tropical Medicine, University of Oxford, with research interests in malaria and tropical diseases. She completed the UBC Clinical Investigator Program and a DPhil in Clinical Medicine at the University of Oxford focused on the pathophysiology and treatment of severe malaria. She continues to work with an international and multidisciplinary team at the Mahidol Oxford Research Unit located in Bangkok, Thailand, focused on the pathophysiology and treatment of severe malaria, and management of sepsis with antimicrobial stewardship in low- and middle-income settings. She has extensive field experience, currently working on active projects in Bangladesh and the Democratic Republic of the Congo. In 2019, Dr. Plewes was awarded a 3-year CIHR Project Grant and MSFHR Health Professional-Investigator award to assess the renoprotective role of acetaminophen in severe pediatric malaria. She is Vancouver Site Lead for the GeoSentinel Surveillance Network, a global network that conducts surveillance of emerging infectious diseases using returning travelers as sentinels of infection. She also represents BC as a committee member and Malaria Subcommittee chair to the Public Health Agency of Canada (PHAC) Canadian Advisory on Tropical Medicine and Travel (CATMAT), and designate BC physician to the PHAC Canadian Malaria Network (CMN). Recent work is focused on collaborating nationally towards creating a Canadian Echinococcosis Registry with colleagues across the country.
Potter, Emery
Emery Potter NP-PHC, BScN, MN (they/them) is a non-binary nurse practitioner in the Transition Related Surgery Program at Women's College Hospital and an adjunct lecturer at the Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto. Emery's work in over the last decade has focused on a diverse range of clinical issues and research topics including: HIV, mental health, harm reduction, mobile health, hepatitis C and 2SLGBTQIA+ health. Emery has provided primary care to hundreds of trans, non-binary and gender diverse individuals including the provision of hormone therapy and pre and postoperative surgical care. Emery has played an essential role in building clinical competencies in trans health across Ontario through the development and implementation of curriculum, training, seminars, and programs. Emery is currently engaged in multiple interdisciplinary and collaborative research projects focused on aspects of transition related surgery such as surgical access, quality improvement, patient reported and post-operative outcomes, pain and the vaginal microbiome. Through research, they hope to better understand the current gaps related to transition related surgery, integrating knowledge gained into clinical care and advocating for broader systemic and policy change.
Proctor, Lily
Dr. Lily Proctor is a surgical gynecologic oncologist at the BC Cancer Agency and at Vancouver General Hospital. She is the medical director of BC Cancer's Cervical cancer screening program and serves as the Provincial cervical cancer colposcopy lead. She obtained her Fellowship in Gynecologic Oncology at UBC followed by a Masters in Clinical Epidemiology and Public Health at the Harvard T.H Chan School of Public Health.
Prodger, Jessica
Dr. Jessica Prodger is an Assistant Professor of Microbiology and Immunology and Director of the Global Health Systems Master of Health Sciences (MHSc) program at Western University in Ontario, Canada. She received her PhD from the University of Toronto and completed Postdoctoral Fellowships at the Johns Hopkins School of Public Health and at the Laboratory for Immunoregulation at the National Institutes of Health. She holds a Tier II Canada Research Chair in Genital Immunology and STI Prevention and her research program at Western focuses on understanding how genital microbiota influence local host immune responses and thus susceptibility to pathogenic genital infections.
Rasmussen, Angela
Dr. Angela (Angie) Rasmussen, PhD is a virologist at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan. Her research focuses on the role of the host in virus susceptibility and pathogenesis, with a particular interest in emerging viruses that are or have the potential to be major threats to global health, such as avian influenza virus, dengue virus, Ebola virus, mpox (monkeypox) virus, MERS-CoV, and SARS-CoV-2. Dr. Rasmussen graduated from Smith College with a BA in Biological Sciences (2000) and received a MA (2005), MPhil (2006), and PhD (2009) in Microbiology and Immunology from Columbia University. She did her postdoctoral fellowship at the University of Washington and previously held faculty positions at the University of Washington and the Columbia Mailman School of Public Health, as well as an affiliation with the Georgetown Center for Global Health Science and Security. In addition to her primary appointment at VIDO, Angie is also an adjunct professor in the Department of Biochemistry, Microbiology, and Immunology at the University of Saskatchewan and an adjunct professor in the Department of Ecology and Evolution at Stony Brook University. She is the co-lead of the Coronavirus Variants Rapid Response Network (CoVaRR-Net) Host-Virus Interactions pillar. She is also a member of the WHO Ad Hoc Expert Committee for Preclinical Models of COVID-19 and sits on the Editorial Boards at Vaccine, mSphere, and Cell Reports. In addition to her research, Dr. Rasmussen is a prolific science communicator on both social media and in the mainstream press, as well as a writer for numerous publications including Forbes, Leaps.org, Slate, Foreign Affairs, the Washington Post, and the New York Times. She is passionate about advocating for equity in biomedical research and public health, and is a member of the US NIH Advisory Committee to the Director Working Group on Changing the Culture to End Sexual Harassment, as well as a faculty mentor for the volunteer science education group Wearing is Caring. She believes strongly that biosecurity and global public health must be collaborative international efforts and is eager to extend this outreach work in Canada and abroad.
Sakoulas, George
Dr. George Sakoulas is an active infectious disease clinician in the Sharp Healthcare System, San Diego, CA and chief of infectious diseases of the Sharp Rees-Stealy Medical Group. He is also an Adjunct Professor in the Division of Host-Microbe Systems and Therapeutics, Center for Immunity, Infection and Inflammation at the University of California San Diego School of Medicine. He has been practicing clinical infectious disease for over 20 years. Dr. Sakoulas received his undergraduate degree from Columbia University and his medical degree from Harvard Medical School. He completed his clinical training in internal medicine and infectious diseases at the Beth Israel Deaconess Medical Center in Boston. Through studying the relationships between antimicrobial resistance and bacterial virulence and the interactions between innate host defense and administered antibiotics, Dr. Sakoulas is working towards developing more effective contemporary therapies for common severe infections by utilizing available drugs. This includes the repurposing of medications used for other diseases as well as with combination antibiotic therapies aimed at virulence attenuation in addition to conventional direct antibacterial effects. By harnessing the cooperativity of some antibiotics with the innate immune response as well as favorable pharmacokinetic properties of antibiotics, Dr. Sakoulas is developing strategies to streamline the therapeutics of infections for the benefit of the patient and healthcare systems.
Saxinger, Lynora
Dr. Saxinger is an Infectious Diseases specialist physician and Professor at the University of Alberta, with a focus on antimicrobial stewardship and antibiotic resistance and utilization surveillance. Early in the pandemic she became engaged in traditional media (over 2500 interviews) and social media (predominantly Twitter) in an effort to counter misinformation. This informs her evolving professional work in disinformation, knowledge translation and science communication to the public.
Schwartz, Kevin
Dr. Kevin Schwartz is the division head for infectious diseases at St. Joseph's Health Centre in Toronto and co-medical director for antimicrobial stewardship at Unity Health Toronto. He is an academic infection control and antimicrobial stewardship physician at Public Health Ontario, an assistant professor at the Dalla Lana School of Public Health at the University of Toronto, and an adjunct scientist at ICES. His clinical area of interest is adult and pediatric infectious diseases and tropical medicine. His research interests include vaccine preventable diseases and antimicrobial stewardship with a particular focus on improving community antibiotic use to slow the emergence of drug resistant infections.
Silverman, Michael
Dr. Silverman received his medical degree and Residency in Internal Medicine at the University of Toronto. He carried out his fellowship in Infectious Diseases at the University of Manitoba in Winnipeg, and an HIV post-doctoral fellowship at the University of California, San Francisco, USA. He is Chair/Chief and Professor of Medicine and Infectious Diseases at Western University. Dr. Silverman is a pioneer in the field of Fecal Microbial Transplantation (FMT) for treatment of Clostridium difficile. He was one of the first to perform the procedure in North America and he has established a large clinical and research program associated with this. He was also the first to demonstrate the effectiveness of FMT in first line therapy of cancer patients on immunotherapy. He has conducted many studies of prevention of infectious complications of injection drug use and has worked extensively in developing countries doing research on HIV and Tropical Infections. He has over 150 peer reviewed publications including recently as a first or senior author in the Annals of Internal Medicine, New England Journal of Medicine, Nature Medicine, JAMA series and Lancet Infectious Diseases. Reviews of his work have been written in Science, Nature and reported in the international mass media including in the New York Times, BBC, CNN, The Times of India, etc.
Szwajcer, David
David Szwajcer is a practicing hematologist in Winnipeg, Manitoba. He functions as the Manitoba Blood and Marrow Transplant Program Director. He is involved in the treatment of patients with complex hematological malignancies using a variety of cellular immunotherapy.
Tam, Ed
Dr. Edward Tam, MD, FRCPC, is a clinical hepatologist in Vancouver, BC. He is active in clinical research, teaching, and clinical care in general outpatient hepatology. He has published extensively in high impact journals and contributed to clinical practice guidelines in the field. Dr. Tam serves as Secretary/Treasurer to the CASL Executive (Canadian Association for the Study of the Liver) and is also a longstanding volunteer board member with the Canadian Liver Foundation BC/Yukon region.
Tam, Jennifer
Dr. Jennifer Tam is a pediatric infectious diseases physician practicing at BC Children’s Hospital in Vancouver, BC. She has been the pediatric infectious diseases subspecialty training program director since 2018. She completed her medical school at the University of British Columbia (UBC), and her pediatric residency and subspecialty training at the Hospital for Sick Children in Toronto. She obtained her Master of Health Professions Education (MHPE) from Maastricht University in partnership with the Centre for Health Education Scholarship at UBC in 2019. When not working, her time is mostly occupied by her 1-year-old son and 3-year-old daughter, reality TV shows, and exploring the Vancouver food scene.
Tran, Vanessa
Dr. Vanessa Tran is a Clinical Microbiologist at Public Health Ontario (PHO) and an Assistant Professor at the University of Toronto. At PHO, she leads the STBBI laboratory portfolio, including testing for HIV, hepatitis viruses, and bacterial STIs. She has led the resident education and professional education portfolios, where she was responsible for program planning and supervision of trainees. She also led COVID-19 serology testing, contributing to several provincial and national serosurveillance studies. Vanessa completed her BSc at the University of Guelph, PhD at the University of Toronto, and Clinical Microbiology Fellowship at the University of Manitoba. She has experience working in hospital, community, and public health microbiology laboratories. Vanessa’s broad areas of interest include molecular diagnostics and molecular epidemiology of infectious diseases of public health significance, particularly the STBBIs.
Tyrrell, Greg
Dr. Tyrrell is a Clinical Microbiologist at the Alberta Provincial Laboratory for Public Health and Professor in the Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta. He did his undergraduate education at the University of Alberta and a PhD degree and Clinical Microbiology Fellowship at the University of Toronto. Subsequently he worked for two years at Dalhousie University in Halifax as a Clinical Microbiologist before returning to the University of Alberta where he is currently located. He has a strong interest in group A and group B streptococci as well as Streptococcus pneumoniae and has worked in the field of streptococci for many years. His interests lie in both the epidemiological aspects of streptococci as well as virulence properties associated with these bacteria.
Waldner, David
Ward, Brian
Dr. Ward received training in Infectious Diseases, Microbiology & Tropical Medicine at McGill University, Oxford University, University of London and Johns Hopkins. He is currently a professor at McGill (1991-present). Since 1991, he has served on many Provincial, National and international advisory committee related to vaccines including the CIHR Institutional Advisory Board for the Institute of Infection & Immunity (chair 2014-2021). Dr Ward is also adjunct faculty at Cayetano Heredia University in Lima, Peru. Throughout his career, he has had close ties with vaccine manufacturers including serving as Medicago's Chief Medical Officer (2017-2023) where he helped license the world’s first vaccine produced in plants (February 2022). His research interests include novel vaccines and adjuvants. He has received a number of awards including a Rhodes scholarship (1977), the US Secretary of Defense Exceptional Public Service Award (2003) and the Quebec Innovation Prize for vaccine development (2020). He has published more than 310 manuscripts and is a fellow of the Canadian Academy of Health Sciences.
Weaver, Victoria
Dr. Victoria Weaver is an adult infectious diseases and addiction medicine physician in Vancouver, British Columbia, and a Clinical Assistant Professor in the Department of Medicine at the University of British Columbia. She trained in internal medicine at the University of Calgary before completing her adult infectious diseases fellowship and addiction medicine training at the University of British Columbia. She currently works as an adult ID physician at Vancouver General Hospital and as an addiction medicine physician at St. Paul's Hospital.